This inventor holds 1 USPTO granted patent. Top assignee: Juno Therapeutics Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Elizabeth Larimore and Polymer-DNA Nanoparticle Stabilization.
Introduction
Elizabeth Larimore is an inventor associated with Seattle, Washington, and Juno Therapeutics GmbH. Her patent work addresses the stabilization of polymer-DNA nanoparticles, with potential relevance to producing viral vectors.
Latest Patents
Larimore is credited with 1 patent: “Stabilization of Polyethyleneimine-Deoxyribonucleic Acid Complex Size and Activity.” The invention describes methods for producing polymer-DNA nanoparticles of a predetermined size. One approach combines a DNA solution with a solution containing a cationic polymer to form a polyplex, then adds a stabilizing agent after a predetermined interval. Controlling the polyplex size may improve nanoparticle transfection efficacy, particularly in suspension cells used for viral-vector production.
Career Highlights
The available information connects Larimore’s patent activity with Juno Therapeutics GmbH. Her listed invention focuses on a technical challenge in gene delivery: maintaining the size and activity of polymer-DNA complexes.
Collaborations
Brynn Olden and Robert Barnes are identified as Larimore’s coworkers. The supplied information does not specify their roles in the patent or the invention.
Conclusion
Elizabeth Larimore’s patent highlights an approach to stabilizing polymer-DNA nanoparticles, with the aim of improving their performance in applications such as viral-vector production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile